Purification of human and avian influenza viruses using cellulose sulfate ester (Cellufine Sulfate) in the process of vaccine production

Microbiology and Immunology

Volumn 56, Issue 7, 2012, Pages 490-495

  Sakoda, Yoshihiro ^a   Okamatsu, Masatoshi ^a   Isoda, Norikazu ^a   Yamamoto, Naoki ^a   Ozaki, Koichi ^a   Umeda, Yasuto ^b   Aoyama, Shigeyuki ^b   Kida, Hiroshi ^a,c  

^a HOKKAIDO UNIVERSITY   (Japan)

^b CHISSO CORPORATION   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Influenza virus; Purification; Sulfate ester; Vaccine

Indexed keywords

CELLULOSE SULFATE; CELLULOSE SULFATE ESTER; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; AMNION FLUID; ARTICLE; ELUTION; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NONHUMAN; VACCINE PRODUCTION; VIRUS HEMAGGLUTINATION; VIRUS PURIFICATION; VIRUS STRAIN;

ADSORPTION; ANIMALS; BIRDS; CHICK EMBRYO; CHROMATOGRAPHY, AFFINITY; HUMANS; INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; POLYMERS; POULTRY DISEASES;

AVIAN INFLUENZA VIRUS; INFLUENZA B VIRUS; ORTHOMYXOVIRIDAE;

EID: 84862906040     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2012.00468.x     Document Type: Article

References (24)

1. Wright P.F., Webster R.G. (2001) Orthomyxoviruses. In: Knipe D.M. & Howley P.M. eds. Fields Virology, 4th edn. Philadelphia: Lippincott Williams & Wilkins, pp. 1533-79.
2. Fiore A.E., Uyeki T.M., Broder K., Finelli L., Euler G.L., Singleton J.A., Iskander J.K., Wortley P.M., Shay D.K., Bresee J.S., Cox N.J. (2010) Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 59: 1-62.
3. Furminger I.G.S. (1998) Vaccine production. In: Nicholson K., Webster R.G., Hay A.J. eds. Textbook of influenza. Oxford: Blackwell Science, pp. 324-32.
4. Gerdil C. (2003) The annual production cycle for influenza vaccine. Vaccine 21: 1776-9.
5. Kalbfuss B., Wolff M., Morenweiser R., Reichl U. (2007) Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnol Bioeng 96: 932-44.
6. Dawood F.S., Jain S., Finelli L., Shaw M.W., Lindstrom S., Garten R.J., Gubareva L.V., Xu X., Bridges C.B., Uyeki T.M. (2009) Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 360: 2605-15.
7. Sugawara K., Nishiyama K., Ishikawa Y., Abe M., Sonoda K., Komatsu K., Horikawa Y., Takeda K., Honda T., Kuzuhara S., Kino Y., Mizokami H., Mizuno K., Oka T., Honda K. (2002) Development of Vero cell-derived inactivated Japanese encephalitis vaccine. Biologicals 30: 303-14.
8. Tamayose K., Hirai Y., Shimada T. (1996) A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum Gene Ther 7: 507-13.
9. Palache A.M., Brands R., Van Scharrenburg G.J. (1997) Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs. J Infect Dis 176 Suppl 1: S20-3.
10. Opitz L., Lehmann S., Zimmermann A., Reichl U., Wolff M.W. (2007) Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses. J Biotechnol 131: 309-17.
11. He C., Yang Z., Tong K. (2011) Downstream processing of Vero cell-derived human influenza A virus (H1N1) grown in serum-free medium. J Chromatogr A 1218:5279-85.
12. Koopmans M., Wilbrink B., Conyn M., Natrop G., Van Der Nat H., Vennema H., Meijer A., Van Steenbergen J., Fouchier R., Osterhaus A., Bosman A. (2004) Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363: 587-93.
13. Peiris J.S., De Jong M.D., Guan Y. (2007) Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 20: 243-67.
14. Itoh Y., Ozaki H., Ishigaki H., Sakoda Y., Nagata T., Soda K., Isoda N., Miyake T., Ishida H., Okamoto K., Nakayama M., Tsuchiya H., Torii R., Kida H., Ogasawara K. (2010) Subcutaneous inoculation of a whole virus particle vaccine prepared from a non-pathogenic virus library induces protective immunity against H7N7 highly pathogenic avian influenza virus in cynomolgus macaques. Vaccine 28:780-9.
15. Itoh Y., Ozaki H., Tsuchiya H., Okamoto K., Torii R., Sakoda Y., Kawaoka Y., Ogasawara K., Kida H. (2008) A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Vaccine 26: 562-72.
16. Soda K., Sakoda Y., Isoda N., Kajihara M., Haraguchi Y., Shibuya H., Yoshida H., Sasaki T., Sakamoto R., Saijo K., Hagiwara J., Kida H. (2008) Development of vaccine strains of H5 and H7 influenza viruses. Jpn J Vet Res 55: 93-8.
17. The World Organization for Animal Health. 5 January 2012. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2011 "Avian Influenza". Avialable from:.
18. Laemmli U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-5.
19. Lamb R.A., Krug R.M. (2001) Orthomyxoviridae: The Viruses and Their Replication. In: Knipe D.M., Howley P.M. eds. Fields Virology, 4th edn. Philadelphia: Lippincott Williams & Wilkins, pp. 1487-531.
20. Krumbiegel M., Dimitrov D.S., Puri A., Blumenthal R. (1992) Dextran sulfate inhibits fusion of influenza virus and cells expressing influenza hemagglutinin with red blood cells. Biochim Biophys Acta 1110: 158-64.
21. Luscher-Mattli M., Gluck R. (1990) Dextran sulfate inhibits the fusion of influenza virus with model membranes, and suppresses influenza virus replication in vivo. Antiviral Res 14: 39-50.
22. Suzuki T., Sometani A., Yamazaki Y., Horiike G., Mizutani Y., Masuda H., Yamada M., Tahara H., Xu G., Miyamoto D., Oku N., Okada S., Kiso M., Hasegawa A., Ito T., Kawaoka Y., Suzuki Y. (1996) Sulphatide binds to human and animal influenza A viruses, and inhibits the viral infection. Biochem J 318: 389-93.
23. Smith B.J., Huyton T., Joosten R.P., Mckimm-Breschkin J.L., Zhang J.G., Luo C.S., Lou M.Z., Labrou N.E., Garrett T.P. (2006) Structure of a calcium-deficient form of influenza virus neuraminidase: implications for substrate binding. Acta Crystallogr D Biol Crystallogr 62: 947-52.
24. Huang Q., Opitz R., Knapp E.W., Herrmann A. (2002) Protonation and stability of the globular domain of influenza virus hemagglutinin. Biophys J 82: 1050-8.